HEALTHDEUTSCHE WELLE
Pancreatic cancer: New drug extends lives but isn't a cure
The newly developed treatment daraxonrasib can double the years left to live for patients with pancreatic cancer, but it does not cure the disease and is only effective if treatment begins early.
Related Signal
Adjacent reporting
- Daily pill doubles survival time for pancreatic cancer patients
- Breakthrough pancreatic cancer treatment could double survival time
- New drug nearly doubles survival rates in some pancreatic cancer patients, study says
- Experimental pill promises new hope for deadly pancreatic cancer
- Daily pill can double survival time for world’s deadliest cancer, trial shows
- Experimental pill promises new hope for deadly pancreatic cancer